GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmiva AB (OSTO:PHARM) » Definitions » 3-Year Revenue Growth Rate

Pharmiva AB (OSTO:PHARM) 3-Year Revenue Growth Rate : 0.00% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Pharmiva AB 3-Year Revenue Growth Rate?

Pharmiva AB's Revenue per Share for the three months ended in Jun. 2023 was kr0.05.

During the past 12 months, Pharmiva AB's average Revenue per Share Growth Rate was 71.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Pharmiva AB's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Pharmiva AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmiva AB's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmiva AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Pharmiva AB's 3-Year Revenue Growth Rate falls into.



Pharmiva AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Pharmiva AB  (OSTO:PHARM) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Pharmiva AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Pharmiva AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmiva AB (OSTO:PHARM) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Sankt Lars Väg 45B, Lund, SWE, 222 70
Pharmiva AB is a medical technology company. It develops innovative antibiotic-free medical products in order to improve vaginal health.

Pharmiva AB (OSTO:PHARM) Headlines

No Headlines